Samantha Semenkow

Stock Analyst at Citigroup

(0)
# 4834
Out of 5,291 analysts
46
Total ratings
20.00%
Success rate
-26.17%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
Bioage Labs
Maintains: Neutral
7 5
3.83 30.55% 3 Mar 24, 2025
Acelyrin
Maintains: Neutral
6 3
2.6 15.38% 2 Jan 7, 2025
Voyager Therapeutics
Initiates Coverage On: Buy
12
3.65 228.77% 1 Dec 2, 2024
argenx
Maintains: Strong Buy
512 635
588.92 7.82% 4 Oct 17, 2024
Allogene Therapeutic...
Maintains: Strong Buy
7 8
1.55 416.13% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 31
24.72 25.4% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 15
1.7 782.35% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
4
0.52 669.23% 2 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 14
2.35 495.74% 6 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
10
1.99 402.51% 2 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 15
1.25 1100% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 12
4.96 141.94% 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
26 30
1.54 1848.05% 2 Apr 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
72
39.88 80.54% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
33 50
18.36 172.33% 3 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 56
22.19 152.37% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 1
n/a n/a 3 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
n/a n/a 1 May 3, 2023